This situation has concluded
It was preserved as a record on September 3; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
5 clusters · 46 sources · 11 days · First seen · Last updated
Shanghai gene‑editing trial fatality
Overview
In March 2025, a six-year-old girl, identified as “Mei,” died seven days after receiving an experimental in-vivo base-editing therapy at Shanghai’s Xinhua Hospital to correct a CHD3 mutation causing Snijders-Blok-Campeau syndrome. Her parents paid approximately US$860,000 for the intrathecal AAV-vector infusion. The hospital’s ethics board and subsequent reports concluded the death was definitely related to the treatment, specifically attributing it to microangiopathic thrombosis caused by the high-dose viral vector.
Investigations by *Science* and *Retraction Watch* revealed that the fatality was deliberately omitted from a related *Nature* paper and was not updated on ClinicalTrials.gov, leading to allegations that the research team attempted to present a false impression of the therapy's safety. While Shanghai Jiao-Tong University’s School of Medicine established a special working group to review the case and the municipal health commission fined the hospital 24,000 yuan (≈US$3,500), no public disciplinary action has been taken against lead researcher Zilong Qiu.
The incident has sparked significant scrutiny of China’s biotechnology sector and its regulatory oversight. Industry leaders have warned that the tragedy could trigger a regulatory backlash, potentially restricting the flexibility of investigator-initiated clinical trials. The case has also reignited global bioethical debates regarding “n-of-1” human gene-editing trials, informed consent, and the necessity for stricter transparency in academic publishing.
Entities
Shanghai Jiao Tong University · Mei (pseudonym) · Zilong Qiu · Xinhua Hospital · Qiu Zilong
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 11 SOURCES] A six‑year‑old Chinese girl died after receiving an experimental in‑vivo base‑editing therapy.
- [● 11 SOURCES] The parents paid US$860,000 to fund the development of the gene‑editing treatment.
- [● 11 SOURCES] The hospital’s ethics board concluded the death was definitely related to the treatment.
- [● 11 SOURCES] The case was omitted from a Nature paper published by the research team.
- [● 11 SOURCES] Shanghai Jiaotong University School of Medicine established a working group to investigate the trial.
- [● 11 SOURCES] Researchers injected trillions of viral vectors carrying a customized gene‑editing system into the girl’s cerebrospinal fluid.
- [● 11 SOURCES] The hospital received only minor administrative penalties and no public disciplinary action against the lead researcher.
- [● 11 SOURCES] The death was attributed to microangiopathic thrombosis linked to the high‑dose AAV viral vector delivery.
- [● 7 SOURCES] A six‑year‑old girl identified as “Mei” died in March 2025 after receiving an experimental brain‑targeted gene‑editing therapy in China.
- [● 7 SOURCES] Mei died within a week of the infusion due to a severe immune reaction.
- [● 6 SOURCES] The death was not reported in the subsequent scientific publication and was uncovered by Science and Retraction Watch.
- [● 6 SOURCES] The hospital received a fine from local health authorities after the child's death.
- [● 6 SOURCES] Researcher Zilong Qiu coordinated the trial, faced scrutiny, but was not publicly sanctioned.
- [● 6 SOURCES] The incident sparked international criticism over research ethics and regulatory compliance.
- [● 5 SOURCES] The trial targeted a CHD3 gene mutation causing Snijders Blok‑Campeau syndrome.
- [● 3 SOURCES] The trial was conducted at Shanghai Xinhua Hospital, affiliated with Shanghai Jiao Tong University School of Medicine.
- [● 3 SOURCES] Neuroscientist Zilong Qiu was the lead researcher of the gene‑editing trial.
- [● 3 SOURCES] Shanghai Jiao Tong University launched a special investigation team and pledged severe measures after the death.
- [● 2 SOURCES] The therapy used intrathecal infusion of adeno‑associated virus vectors delivering a base‑editing tool to correct a genetic mutation.
- [● 2 SOURCES] Mei’s parents contributed roughly US$800,000–US$860,000 to fund the experimental therapy.
- [○ 1 SOURCE] Biotech industry leaders fear the incident could trigger a regulatory backlash in China that might restrict investigator‑initiated trials.
- [○ 1 SOURCE] The hospital was fined 24,000 yuan (≈US$3,500) for regulatory violations related to the trial.
Timeline
-
[HEALTH] 7 sourcesChina gene‑editing trial kills 6‑year‑old girl
A six‑year‑old Chinese girl died weeks after an experimental brain‑targeted gene‑editing therapy at Shanghai Xinhua Hospital, prompting a university investigation and global ethical debate.
-
[HEALTH] 12 sourcesShanghai Xinhua Hospital gene‑editing trial kills six‑year‑old girl
A six‑year‑old Chinese girl died after an experimental base‑editing gene therapy at Shanghai Xinhua Hospital; parents paid $860 k, ethics board linked death to treatment, and a university investigation was启动.
-
[HEALTH] 5 sourcesShanghai Jiao Tong University gene‑editing trial kills 6‑year‑old girl
A 6‑year‑old girl died a week after an experimental gene‑editing therapy at Shanghai Jiao Tong University; parents paid $800k, neuroscientist Zilong Qiu led the trial, prompting a university investigation and a
-
[HEALTH] 7 sourcesShanghai child’s death prompts probe of experimental gene‑editing therapy
A 6‑year‑old Chinese girl died a week after an experimental CRISPR gene‑editing therapy in Shanghai; the hidden death, funded at $860 k, led to a university probe, health‑authority fine, and scrutiny of lead‑re
-
[HEALTH] 17 sourcesShanghai girl's death in experimental gene‑editing trial sparks international investigation
A six‑year‑old Chinese girl died a week after an experimental brain gene‑editing therapy in 2025; investigators say Chinese researchers and authorities hid the fatal outcome, sparking an ethics scandal.
Sources
1001infos.net · adevarul.ro · aeiou.pt · archynetys.com · archynewsy.com · arroyodiario.com.ar · arts-spectacles.com · bionews.org.uk · dbarchitects.com · deia.eus · dgabc.com.br · diariodelsur.com.co · elcorreoweb.es · entornointeligente.com · epochtimes.com · extra.com.co · gizmodo.com · gizmodo.es · hsbnoticias.com · index.hr · infotrend.hr · kesq.com · keyt.com · krdo.com · kvia.com · lacronicabadajoz.com · laopinioncoruna.es · litaliano.it · m.scmp.com · m.secretchina.com · marcelrizzo.blogosfera.uol.com.br · massinformacion.com.mx · metropoles.com · ndmais.com.br · nemosnewsnetwork.com · newscentral.africa · ocio.farodevigo.es · ratb.ro · retetesivedete.ro · sapo.pt · singtao.com · startup.mandiner.hu · stiripesurse.ro · thecritique.com · ultimosegundo.ig.com.br · visiontimes.com
This summary has been updated 10 times: see revision history